NanoViricides
NNVC
#10112
Rank
ยฃ17.75 M
Marketcap
ยฃ0.99
Share price
-3.65%
Change (1 day)
-15.04%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: ยฃ17.75 Million

As of December 2025 NanoViricides has a market cap of ยฃ17.75 Million. This makes NanoViricides the world's 10112th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ17.75 M3.51%
2024ยฃ17.14 M82.36%
2023ยฃ9.4 M-11.72%
2022ยฃ10.65 M-66.46%
2021ยฃ31.76 M41.44%
2020ยฃ22.45 M203.1%
2019ยฃ7.4 M-32.34%
2018ยฃ10.95 M-73.45%
2017ยฃ41.24 M-18.28%
2016ยฃ50.47 M9.62%
2015ยฃ46.04 M-53.41%
2014ยฃ98.82 M-32.14%
2013ยฃ0.14 B214.56%
2012ยฃ46.29 M-21.02%
2011ยฃ58.61 M-55.65%
2010ยฃ0.13 B90.75%
2009ยฃ69.28 M2.17%
2008ยฃ67.81 M189.92%
2007ยฃ23.39 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of NanoViricides was reported to be:

ยฃ18.28 Million
by Nasdaq info icon info icon
ยฃ18.42 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
ยฃ1.20 B 6,688.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.81 B 4,510.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ112.49 B 633,673.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ77.89 B 438,739.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ182.19 B 1,026,306.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ73.06 B 411,519.86%๐Ÿ‡ฌ๐Ÿ‡ง UK